Literature DB >> 6547370

Development of new drugs for endocrine tumour chemotherapy.

E von Angerer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6547370     DOI： 10.1016/0305-7372(84)90054-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

1.  Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.

Authors:  W Schwarz; R W Hartmann; J Engel; M R Schneider; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.

Authors:  E von Angerer; J Prekajac; M R Schneider; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Palladium-catalyzed nucleomethylation of alkynes for synthesis of methylated heteroaromatic compounds.

Authors:  Xi Yang; Gang Wang; Zhi-Shi Ye
Journal:  Chem Sci       Date:  2022-08-18       Impact factor: 9.969

4.  Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.

Authors:  R C Stein; M Dowsett; D C Cunningham; J Davenport; H T Ford; J C Gazet; E von Angerer; R C Coombes
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.